Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

DSpace Repository

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Author: Rossing, Peter; Anker, Stefan D.; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M.; Birkenfeld, Andreas L.; McGill, Janet B.; Rosas, Sylvia E.; Joseph, Amer; Gebel, Martin; Roberts, Luke; Scheerer, Markus F.; Bakris, George L.; Agarwal, Rajiv
Tübinger Autor(en):
Birkenfeld, Andreas L.
Published in: Diabetes Care (2022), Bd. 45, H. 12, S. 2991-2998
Verlagsangabe: Amer Diabetes Assoc
Language: English
Full text: http://dx.doi.org/10.2337/dc22-0294
ISSN: 0149-5992
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)